Search company, investor...

Predict your next investment

Corporate Venture
desjardins-capital.com

Investments

96

Portfolio Exits

12

Funds

6

About Desjardins Capital

Desjardins Capital is the development capital fund management arm of Desjardins Group. It fuels the expansion of SMEs and cooperatives alike by providing them with the strategic and financial support needed. By investing in all regions of Quebec and in all major business sectors with strong growth potential, it has become one of the most solidly established and active development capital companies in Quebec.

Headquarters Location

2, Complexe Desjardins, bureau 1717 tour est, C.P. 760, Succursale Desjardins

Montreal, Quebec, H5B 1B8,

Canada

Want to inform investors similar to Desjardins Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Desjardins Capital News

Four Canadian Health Tech stocks rated by Desjardins

Mar 10, 2023

Four Canadian Health Tech stocks rated by Desjardins Things are looking up for the Healthcare Technology space, according to Desjardins Capital Markets who delivered on Thursday an update on the sector. The report says demographics, overworked healthcare systems and growing interest in private health care provision are all looking like tailwinds for stocks. Desjardins analyst Jerome Dubreuil argued that an industry-wide shortage of practitioners is part of the picture, pointing to a rash of 13 healthcare worker strikes in the United States over the past 12 months as evidence, where workers are saying they’re understaffed and overworked, leading to higher burnout rates and higher employee turnover. The result is an environment which is ripe for more investment in technology to help ease some of the burdens on healthcare systems, the analyst said. “We believe it could become more difficult for healthcare workers to address the growing burden they face unless decision-makers accept the need to invest more in technology,” Dubreuil wrote. On the Canadian side, Dubreuil noted recent moves by the Ontario government to involve private sector clinics in easing the backlog of procedures built up over the pandemic, along with a recent poll of Quebecers which suggested the population is more amenable to private sector involvement to support provincial healthcare delivery. Dubreuil said expansion of private clinics would be good for a number of companies, including WELL Health Technologies and Think Research. The analyst also noted the increase in use of telehealth services will be of benefit to companies like WELL Health and Dialogue Health Technologies. “While practitioner shortages may also affect private companies, we believe the data suggests the gap between the demand and supply of healthcare services is widening. We believe this trend, coupled with greater willingness on the part of governments in Canada to allow more private sector involvement in the healthcare sector, should benefit the healthcare technology companies we cover,” he said.

Desjardins Capital Investments

96 Investments

Desjardins Capital has made 96 investments. Their latest investment was in Puzzle Medical Devices as part of their Series A on February 2, 2023.

CBI Logo

Desjardins Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/27/2023

Series A

Puzzle Medical Devices

$25.03M

Yes

2

2/14/2023

Series A

PreVu3D

$10M

No

4

1/19/2023

Unattributed VC

Cegerco

Yes

1

11/22/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

10/21/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/27/2023

2/14/2023

1/19/2023

11/22/2022

10/21/2022

Round

Series A

Series A

Unattributed VC

Series B

Series A

Company

Puzzle Medical Devices

PreVu3D

Cegerco

Subscribe to see more

Subscribe to see more

Amount

$25.03M

$10M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

4

1

10

10

Desjardins Capital Portfolio Exits

12 Portfolio Exits

Desjardins Capital has 12 portfolio exits. Their latest portfolio exit was oxio on February 21, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/21/2023

Acquired

$99M

5

8/3/2021

Acquired

$99M

3

3/23/2021

Acquired

$99M

9

2/17/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

1/26/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/21/2023

8/3/2021

3/23/2021

2/17/2021

1/26/2021

Exit

Acquired

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

5

3

9

10

10

Desjardins Capital Acquisitions

2 Acquisitions

Desjardins Capital acquired 2 companies. Their latest acquisition was P.H. Tech on June 17, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/17/2022

$99M

Management Buyout

3

10/11/2013

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/17/2022

10/11/2013

Investment Stage

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

Note

Management Buyout

Subscribe to see more

Sources

3

10

Desjardins Capital Fund History

6 Fund Histories

Desjardins Capital has 6 funds, including Desjardins Capital Fintech Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/10/2019

Desjardins Capital Fintech Fund

$34M

1

11/23/2015

Capital regional et cooperatif Desjardins

Subscribe to see more

Subscribe to see more

$99M

10

12/31/2008

Innovatech SEC

Subscribe to see more

Subscribe to see more

$99M

10

Capital croissance PME

Subscribe to see more

Subscribe to see more

10

Transatlantic Fund

Subscribe to see more

Subscribe to see more

10

Closing Date

6/10/2019

11/23/2015

12/31/2008

Fund

Desjardins Capital Fintech Fund

Capital regional et cooperatif Desjardins

Innovatech SEC

Capital croissance PME

Transatlantic Fund

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$34M

$99M

$99M

Sources

1

10

10

10

10

Desjardins Capital Team

1 Team Member

Desjardins Capital has 1 team member, including former Chief Operating Officer, Louis L Roquet.

Name

Work History

Title

Status

Louis L Roquet

Chief Operating Officer

Former

Name

Louis L Roquet

Work History

Title

Chief Operating Officer

Status

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.